VirnetX Holding (VHC) Research & Development (2010 - 2026)

VirnetX Holding (VHC) has 17 years of Research & Development data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 7.7% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (down 7.83% YoY), and the FY2025 full-year result was $5.7 million, down 6.36% from the prior year.
• Research & Development retreated to $1.2 million in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $4.8 million in Q2 2023 to a low of $1.1 million in Q3 2025.
• A 5-year average of $1.7 million and a median of $1.3 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 278.88% in 2023 and tumbled 74.28% in 2024, its largest moves.
• Tracing VHC's Research & Development over 5 years: stood at $2.7 million in 2022, then dropped by 12.41% to $2.4 million in 2023, then declined by 0.04% to $2.4 million in 2024, then declined by 14.09% to $2.0 million in 2025, then slumped by 42.96% to $1.2 million in 2026.
• Business Quant data shows VHC's Research & Development at $1.2 million in Q1 2026, $2.0 million in Q4 2025, and $1.1 million in Q3 2025.